BackEvolving Evidence in the Role of Empagliflozin in Kidney Diseases
25 November 2022
- Click on the timestamp to jump to the topic you are interested in.
- 00:00:22 Inspirational video 00:05:31 Opening by Dr Allen Marlon Costales 00:06:51 Introductions by Dr Adrian Liew 00:11:55 Session 1: Prof Michel Jadoul 00:12:40 The burden of CKD: Prevalence, associated cardiovascular risk, mortality cost 00:23:52 The importance of screening for CKD 00:30:27 The unmet screening and treatment needs 00:35:07 Current and future guidelines for the management of CKD 00:38:44 Conclusion 00:39:44 Session 2: Prof Per Henrik Groop 00:40:11 DKD is a common complication 00:41:24 The consequences DKD 00:42:13 SGLT2 inhibitors on top of SOC: CVOTs 00:45:37 SGLT2 inhibitors on top of SOC: RCTs in heart failure patients 00:48:54 SGLT2 inhibitors on top of SOC: RCTs in kidney patients 00:52:25 SGLT2 inhibitors on top of SOC: EMPA-KIDNEY 01:08:57 EMPA-KIDNEY: Summary 01:10:03 Take-home messages 01:11:37 Q&A 01:23:34 Summary and closing by Dr Adrian Liew
×
Prof Per Henrik Groop
University of Helsinki, Finland
- Professor of Internal Medicine (Chair) at the University of Helsinki
- Graduated from Medicine the University of Helsinki and postdoctoral studies at the Guy’s Hospital, University of London
- Chief Physician at the Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital
- Principal Investigator of the Finnish Diabetic Nephropathy (FinnDiane) Study at the Folkhälsan Research Center in Helsinki, Finland
- Professor at the Department of Diabetes, Central Clinical School at the Monash University in Melbourne, Australia
- Research is focused on the dissection of the pathogenesis of diabetic complications with special emphasis on diabetic nephropathy
×
Prof Michel Jadoul
Universitaires St-Luc Brussel Belgium
- Head of the Department of Nephrology Cliniques Universitaires St-Luc received his medical degree at the Université catholique de Louvain (UCL)
- Full Clinical Professor at Université catholique de Louvain
- He is theme Editor of Nephrology Dialysis Transplantation
- He is country co-investigator for the DOPPS
- International distinguished medal of the National Kidney Foundation in 2008
- Member of the KDIGO Executive Committee (2010-2015) and co-chair of KDIGO since 2019
- Member of the Council of the ERA-European Dialysis and Transplant Association, International Society of Nephrology, American Society of Nephrology and Société Belge de Néphrologie
- He has authored and co-authored over 330 scientific papers (H index:59), published in major nephrology journals
×
Dr Adrian Liew
Mount Elizabeth Novena Specialist Centre Singapore
- Senior Consultant Nephrologist & Director The Kidney & Transplant Practice
- Bachelor of Medicine & Bachelor of Surgery - MBBS (Singapore) at National University of Singapore
- Masters of Clinical Epidemiology with Distinction – University of Newcastle Australia
- Fellow of Academy of Medicine, Singapore – FAMS Chapter of Renal Physicians, Fellow of American Society of Nephrology – FASN American Society of Nephrology and Fellow of Royal College of Physicians of Edinburgh - FRCP (Edin) Royal College of Physicians of Edinburgh, United Kingdom
- Chairman, South East Asia Glomerulonephritis Network (SEA-GN), Chairman ASEAN Peritoneal Dialysis Network, Member International Society for Peritoneal Dialysis Standards and Guidelines Committee Member of the Asian Pacific Society of Nephrology Continuing Medical Education and the Dialysis Working Group International Society of Nephrology Committee
